The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Opioid dependence remains a major driver of death and disease worldwide
Subscribe To Our Newsletter & Stay Updated
